InvestorsHub Logo
Followers 51
Posts 9111
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Thursday, 10/27/2022 11:27:28 PM

Thursday, October 27, 2022 11:27:28 PM

Post# of 13489
MERCK beats estimates. Article talks about collaboration with MRNA on cancer treatment.

The new vaccine, Moderna said, is undergoing mid-stage trials with data expected before the end of the year.


https://www.thestreet.com/markets/merck-stock-jumps-keytruda-drives-q3-profit-beat-forecast-boost?puc=yahoo&cm_ven=YAHOO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News